Phone (Mobile)
+1 831 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(510) 204-7200
Phone (HQ)
❅❅❅❅❅@xoma.com
❅❅❅❅❅@yahoo.com
Office Address (HQ)
2200 Powell St Ste 310, Emeryville, California, 94608, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Christopher Baldwin
According to Datanyze information, these are Christopher Baldwin's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 831 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(510) 204-7200
Phone (HQ)
❅❅❅❅❅@xoma.com
❅❅❅❅❅@yahoo.com
Office Address (HQ)
2200 Powell St Ste 310, Emeryville, California, 94608, United States
Office Address (HQ)
Christopher Baldwin works as a Vice President, Legal at XOMA, which is a Business Services company with an estimated 12 employees; and founded in 1981. They are part of the Legal team within the Legal Department and their management level is VP-Level. Christopher graduated from University of California at Berkeley and is currently based in Palo Alto, United States. They used to work at Jazz Pharmaceuticals and Jazz Pharmaceuticals and have used the following emails: @xoma.com, @jazzpharma.com, @adverum.com.
Flattery will get you everywhere, offer Christopher a compliment to ❄️
Christopher Baldwin's career began less then a year ago. Prior to joining XOMA, Christopher worked at 10 companies.
Executive Director, Senior Corporate Counsel
Brands, Hematology & Oncology Corporate Counsel (US)
Commercial & Operations Corporate Counsel
Associate
Co-Founder
Summer Associate
Stanford University and U.C. Berkeley
Graduate Student
Business Analyst & Manager, Technology Development
Systems Engineer
Medicinal Chemist
B. S. Degree
University of California at Berkeley
MBA
Stanford University
J. D.
University of California at Berkeley
XOMA
2200 Powell St Ste 310, Emeryville, California, 94608, United States
12
$4.4 M
Business Services, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about XOMA - Christopher Baldwin’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Christopher’s company in the news
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
April 25, 2024
XOMA Declares Quarterly Preferred Stock Dividends - March 21, 2024 - BioSpace
March 21, 2024
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent ...
March 8, 2024
See more
Insights to Break the Ice
In your first interaction
Christopher is located in United States
Work Colleague
See Christopher Baldwin's coworkers out of XOMA's 12 employees